Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 36B pseudogene 1 (ANKRD36BP1) is classified as a human pseudogene located on chromosome 12 and is related to the ankyrin repeat domain protein family[3][5]. The gene is transcribed in multiple tissues, including the brain, but its function remains unknown and it is primarily annotated with protein binding as a predicted molecular function[4][6][7]. There is no evidence that it encodes a functional protein in vivo or acts as a therapeutic target, and currently there are no known disease associations, drug interactions, or biomarker roles[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 36B pseudogene 1 (ANKRD36BP1).